Ensol Biosciences Inc. (XKON:140610)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,750
-150 (-1.08%)
At close: Apr 28, 2026

Ensol Biosciences Market Cap

Ensol Biosciences has a market cap or net worth of 186.26 billion as of April 29, 2026. Its market cap has decreased by -35.31% in one year.

Market Cap
186.26B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,750.00

Market Cap Chart

Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 186.26B, an increase of 75.38%. That is a compound annual growth rate of 7.63%.

History

DateMarket Cap% Change
Apr 28, 2026186.26B6.08%
Dec 30, 2025175.59B-10.18%
Dec 30, 2024195.49B264.72%
Dec 28, 202353.60B-23.21%
Dec 29, 202269.80B-47.06%
Dec 30, 2021131.85B5.52%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Prestige Biologics 185.83B
ISU Abxis 201.00B
QuadMedicine 164.54B
Genome & Company 221.57B
ViGenCell 226.93B
ABION 236.52B
CORESTEMCHEMON 144.84B
BIO-FD&C 125.48B
Market Cap Rankings